University Medical Center Groningen: Esophageal Neoplasms trials

The registry lists 14 Esophageal Neoplasms studies with University Medical Center Groningen as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 1 4Phase 2 2No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Optical PD-1 and PD-L1 Imaging in Locally Advanced Esophageal Cancer Using Durvalumab-680LT and Nivolumab-800CWNot yet recruitingNCT07196384Phase 1
• Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administration of Indocyanine Green During Endoscopic Submucosal DissectionRecruitingNCT07108855Phase 1/2
• Home Monitoring During ChemoradiationRecruitingNCT06597240
• Prediction Models for Complications After CRT in Esophageal CancerRecruitingNCT06366828
• CPAP or BiPAP for Motion Mitigation During RadiotherapyRecruitingNCT04986293Not applicable
• Organoid Based Response Prediction in Esophageal CancerRecruitingNCT03283527
• Standard Follow-Up Program (SFP) for Patients With Esophageal CancerRecruitingNCT02454790
• BReath Hold TecHniquEs for Radiotherapy of Esophageal CarcinomaTerminatedNCT06317272Not applicable
• Quantitative Fluorescence Endoscopy Using Durvalumab-680LT in Esophageal CancerCompletedNCT05450484Phase 1
• Detection of Early Esophageal Cancer by NIR-FME.Status unknownNCT03877601Phase 2
• Fluorescence Endoscopy of Esophageal CarcinomaTerminatedNCT03558724Phase 1
• Detection of (Sub)Clinical Toxicity in Irradiated vs. Non-irradiated Surgically Treated Esophageal Cancer Patients: a Pilot Study (CROSS SECT)CompletedNCT03396614
• PET-CT vs DWI-MRI in Response Evaluation in Esophageal CancerCompletedNCT02839109
• Value of PET-CT in Radiation Treatment Planning for Patients With Esophageal CancerCompletedNCT01836913